In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1In-vitro activity of Sch 29482 in comparison with other oral antibiotics1982 · 21 citations
2. 2Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent1990 · 16 citations
3. 3Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.1983 · 257 citations
4. 4Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates1991 · 58 citations
5. 5Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci1992 · 22 citations